|
1
|
Lum L and Beachy PA: The Hedgehog response
network: sensors, switches, and routers. Science. 304:1755–1759.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hao K, Tian XD, Qin CF, Xie XH and Yang
YM: Hedgehog signaling pathway regulates human pancreatic cancer
cell proliferation and metastasis. Oncol Rep. 29:1124–1132.
2013.PubMed/NCBI
|
|
3
|
Lauth M and Toftgård R: Non-canonical
activation of GLI transcription factors: implications for targeted
anti-cancer therapy. Cell Cycle. 6:2458–2463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dennler S, André J, Alexaki I, et al:
Induction of sonic hedgehog mediators by transforming growth
factor-β: Smad3-dependent activation of Gli2 and Gli1 expression
in vitro and in vivo. Cancer Res. 67:6981–6986.
2007.
|
|
5
|
Bhardwaj G, Murdoch B, Wu D, et al: Sonic
hedgehog induces the proliferation of primitive human hematopoietic
cells via BMP regulation. Nat Immunol. 2:172–180. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Detmer K, Walker AN, Jenkins TM, Steele TA
and Dannawi H: Erythroid differentiation in vitro is blocked
by cyclopamine, an inhibitor of hedgehog signaling. Blood Cells Mol
Dis. 26:360–372. 2000.
|
|
7
|
Bai LY, Chiu CF, Lin CW, Hsu NY, Lin CL,
Lo WJ and Kao MC: Differential expression of sonic hedgehog and
Gli1 in hematological malignancies. Leukemia. 22:226–228. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobune M, Takimoto R, Murase K, et al:
Drug resistance is dramatically restored by hedgehog inhibitors in
CD34+ leukemic cells. Cancer Sci. 100:948–955. 2009.PubMed/NCBI
|
|
9
|
Fortunel N, Hatzfeld J, Kisselev S, et al:
Release from quiescence of primitive human hematopoietic
stem/progenitor cells by blocking their cell-surface TGF-β type II
receptor in a short-term in vitro assay. Stem Cells.
18:102–111. 2000.PubMed/NCBI
|
|
10
|
Fortunel NO, Hatzfeld A and Hatzfeld JA:
Transforming growth factor-β: pleiotropic role in the regulation of
hematopoiesis. Blood. 96:2022–2036. 2000.
|
|
11
|
Jinnin M, Ihn H and Tamaki K:
Characterization of SIS3, a novel specific inhibitor of Smad3, and
its effect on transforming growth factor-β1-induced extracellular
matrix expression. Mol Pharmacol. 69:597–607. 2006.PubMed/NCBI
|
|
12
|
Bale AE: Hedgehog signaling and human
disease. Annu Rev Genomics Hum Genet. 3:47–65. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hui CC and Angers S: Gli proteins in
development and disease. Annu Rev Cell Dev Biol. 27:513–537. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duman-Scheel M, Weng L, Xin S and Du W:
Hedgehog regulates cell growth and proliferation by inducing Cyclin
D and Cyclin E. Nature. 417:299–304. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai K, Kaspar BK, Gage FH and Schaffer DV:
Sonic hedgehog regulates adult neural progenitor proliferation
in vitro and in vivo. Nat Neurosci. 6:21–27. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bigelow RL, Chari NS, Unden AB, et al:
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog
signaling pathway through gli-1. J Biol Chem. 279:1197–1205. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watkins DN, Berman DM, Burkholder SG, Wang
B, Beachy PA and Baylin SB: Hedgehog signalling within airway
epithelial progenitors and in small-cell lung cancer. Nature.
422:313–317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spinella-Jaegle S, Rawadi G, Kawai S, et
al: Sonic hedgehog increases the commitment of pluripotent
mesenchymal cells into the osteoblastic lineage and abolishes
adipocytic differentiation. J Cell Sci. 114:2085–2094. 2001.
|
|
19
|
O’Flaherty JD, Barr M, Fennell D, Richard
D, Reynolds J, O’Leary J and O’Byrne K: The cancer stem-cell
hypothesis: its emerging role in lung cancer biology and its
relevance for future therapy. J Thorac Oncol. 7:1880–1890.
2012.PubMed/NCBI
|
|
20
|
Weiss GJ and Korn RL: Metastatic basal
cell carcinoma in the era of hedgehog signaling pathway inhibitors.
Cancer. 118:5310–5319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Irvine DA and Copland M: Targeting
hedgehog in hematologic malignancy. Blood. 119:2196–2204. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kasper M, Regl G, Frischauf AM and Aberger
F: GLI transcription factors: mediators of oncogenic hedgehog
signalling. Eur J Cancer. 42:437–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai CB, Auerbach W, Lee JS, Stephen D and
Joyner AL: Gli2, but not Gli1, is required for initial Shh
signaling and ectopic activation of the Shh pathway. Development.
129:4753–4761. 2002.PubMed/NCBI
|
|
24
|
Ikram MS, Neill GW, Regl G, et al: GLI2 is
expressed in normal human epidermis and BCC and induces GLI1
expression by binding to its promoter. J Invest Dermatol.
122:1503–1509. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruiz I and Altaba A: Gli proteins encode
context-dependent positive and negative functions: implications for
development and disease. Development. 126:3205–3216.
1999.PubMed/NCBI
|
|
26
|
Roberts AB and Sporn MB: Transforming
growth factor-β. Adv Cancer Res. 51:107–145. 1988.
|
|
27
|
Massagué J: How cells read TGF-β signals.
Nat Rev Mol Cell Biol. 1:169–178. 2000.
|
|
28
|
Attisano L and Wrana JL: Signal
transduction by the TGF-β superfamily. Science. 296:1646–1647.
2002.
|
|
29
|
Piacibello W, Severino A, Stacchini A and
Aglietta M: Differential effects of transforming growth factor beta
1 on the proliferation of human lymphoid and myeloid leukemia
cells. Haematologica. 76:460–466. 1991.PubMed/NCBI
|
|
30
|
Chen Y, Lu L and Wang L: Study on gene
expression of TGF β1 and its receptor in leukemia cells and the
serum TGF β1 level in the patients with acute leukemia. Zhonghua
Xue Ye Xue Za Zhi. 19:576–580. 1998.(In Chinese).
|
|
31
|
Testa U, Masciulli R, Tritarelli E, et al:
Transforming growth factor-β potentiates vitamin D3-induced
terminal monocytic differentiation of human leukemic cell lines. J
Immunol. 150:2418–2430. 1993.
|
|
32
|
Gough PJ and Raines EW: Advances in
retroviral transduction of hematopoietic stem cells for the gene
therapy of atherosclerosis. Curr Opin Lipidol. 14:491–497. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kasperczyk H, Baumann B, Debatin KM and
Fulda S: Characterization of sonic hedgehog as a novel NF-κB target
gene that promotes NF-κB-mediated apoptosis resistance and tumor
growth in vivo. FASEB J. 23:21–33. 2009.PubMed/NCBI
|
|
34
|
De Benedetti F, Falk LA, Ellingsworth LR,
Ruscetti FW and Faltynek CR: Synergy between transforming growth
factor-β and tumor necrosis factor-α in the induction of monocytic
differentiation of human leukemic cell lines. Blood. 75:626–632.
1990.
|
|
35
|
ten Dijke P and Hill CS: New insights into
TGF-β-Smad signalling. Trends Biochem Sci. 29:265–273. 2004.
|
|
36
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Genes Dev. 19:2783–2810. 2005.PubMed/NCBI
|
|
37
|
Roberts AB, Anzano MA, Wakefield LM, Roche
NS, Stern DF and Sporn MB: Type β transforming growth factor: a
bifunctional regulator of cellular growth. Proc Natl Acad Sci USA.
82:119–123. 1985.
|
